5 best water flossers of 2025, tested and reviewed
If you know you should floss but just can't seem to get into the habit, you're not alone. Only about one third of American adults floss daily. But while regular flossing may not be the norm, it's a vital part of a healthy oral care routine. Flossing protects against tooth decay, bad breath and gum disease and may reduce the risk of heart problems, stroke and cognitive decline.
The American Dental Association recommends brushing for two minutes twice daily and flossing once daily to prevent the development of gum diseases such as gingivitis. If the idea of threading a piece of string between your teeth makes you shudder, we have good news! Water flossers — handheld devices that use a steady stream of water to clear debris from the teeth and gumline — may be even more effective than floss.
And according to the American Dental Association (ADA), water flossing is an excellent alternative for those with dental work that makes traditional flossing challenging, such as those with crowns, bridges, braces or implants.
Another note to all the parents out there: It's never too early to start flossing. "Children should begin flossing when they have two teeth that touch, typically around the age of 2 or 3," says Casey Johnson, DDS, a board-certified orthodontist who practices in Colorado. "It's generally recommended to start with regular dental floss to ensure that proper technique and habits are established." But if kids find floss hard to use, a water flosser can be an effective alternative, says Johnson, if used under adult supervision.
He recommends the Waterpik brand because "it is easy to use, durable and has everything you would need for a water flosser." Other brands may have more bells and whistles, "but Waterpik is a simple solution that does the job well at a relatively low cost for the consumer," Johnson says.
After testing 14 products and speaking with a number of dentists about what to look for in a high-quality water flosser, I agree: Waterpik earns the top spot for best water flosser. That said, there are four other flossers that stand out for a number of reasons, whether you're on a budget, you're looking for a long-lasting battery or you want a flosser you can take with you when you travel. So read on to discover which water flossers made the cut (and which ones didn't).
Best overall water flosser
More water flossers we like
Traditional dental floss vs. water flossers
Factors to consider when purchasing a water flosser
What to look for in a water flosser
How we chose the best water flosser
FAQs
Other products we tested
Meet our experts
Related: We also compiled a list of the best electric toothbrushes you can buy to boost your oral hygiene. And check out our list of the best at-home teeth whitening products to help you get that Hollywood smile.
Update, June 9, 2025: We checked all product prices and availability. We tested five additional options, but our top pick is unchanged.
(back to top)
Experts agree that a water flosser should supplement rather than replace traditional flossing in most cases. "While water flossers are effective, regular floss remains the gold standard for flossing because it can reach slightly under the gums, providing better removal of food particles and plaque," says Chelsea Perry, DMD, a dentist practicing in Westborough, Mass.
(back to top)
When choosing the best water flosser, it's essential to think about your health and lifestyle needs. Here's what to consider:
Gum sensitivity: Look for models with adjustable pressure settings and gentle pulse modes.
Orthodontics, implants and crowns: Choose a flosser with specialized nozzles for braces and other dental appliances. Ensure the flosser has tips designed to effectively clean around implants and crowns.
Lifestyle: Do you travel frequently? If so, opt for a cordless, rechargeable model that's compact and easy to pack.
Space availability: Select a design that fits comfortably in your bathroom, especially if space is limited.
Affordability: Find a model that fits your budget without compromising essential features.
(back to top)
Here are the factors to look for when shopping for a water flosser:
Type: Countertop or cordless? A countertop model offers more power but requires space and an outlet, while a cordless model is portable, rechargeable and travel-friendly.
Water pressure settings: Perry points out that adjustable pressure settings can accommodate different sensitivity levels.
Water capacity: To avoid frequent refills as you floss, consider the flosser's water capacity — a larger reservoir means you may be able to get through a full session without having to stop to add more water. Just be aware that Perry advises against leaving water in the reservoir between uses.
Nozzles: Check for a variety of nozzles to address different dental needs.
Pulsation frequency: Ensure the flosser offers effective pulsation for thorough cleaning.
Features: Do you need normal, soft or massage pulse modes to enhance your flossing routine? What about a pause button to control water flow or a water pressure indicator for precise control? Perry adds that a rotating nozzle helps reach all areas of your mouth.
Design and ergonomics: Evaluate how the flosser fits into your space and how comfortable it is to hold and use. Perry adds that she avoids flossers with overly complex controls and those that are difficult to clean.
Price: More expensive doesn't always mean better. Quality options are available for every budget.
Warranty: Check for a warranty to ensure your investment is protected.
As dental hygienist JoAnn Gurenlian, a Proclaim Health adviser, points out, "The best option when it comes to toothbrushes, flossing and beyond is always the one that the patient will use regularly."
So, spend some time doing your homework and choosing the best option for you.
(back to top)
We did our research, contacted multiple dentists and dental health experts, including the American Dental Association, and spoke to almost a dozen longtime water flosser users to select the 14 products we tested.
All testers completed a standardized rating form for each product they tested, and based on their ratings and notes, the final product selections were determined.
(back to top)
Yes and no, according to the research and the experts. Even proponents of water flossers concede that traditional flossing produces the best results if done frequently. But that's the key: frequency. "Water flossers require less effort and therefore are used more frequently than traditional floss," says Johnson.
Yes. Some water flossers tout their effectiveness for people with implants or orthodontics, and many of the dentists we spoke to said they recommend them for patients in those categories.
"We have patients tell us they will use normal floss," says Johnson, "but after a few appointments, it's clear that they haven't flossed at all. We have found that patients who use water flossers use them much more frequently and often have healthier gums."
At least once a day for 60 seconds. The best time to floss is at night before bed. Perry's nighttime routine is to brush for two minutes, floss with traditional floss and then use a water flosser.
"People with periodontal disease should not use a water flosser because the force of the water jet can potentially push bacteria deeper into the gum pockets, exacerbating the condition," says Perry.
An electric toothbrush can help you get to hard-to-reach tooth surface areas. A water flosser can get between teeth and below the gumline, but it doesn't clean the tooth surface.
It depends on your preferences and needs. Countertop models generally provide more flossing tips for family use but take up more space and need a power outlet. Cordless water flossers are rechargeable, portable and convenient. They often come with various flossing tips designed for different purposes, although they may be less suitable for multiple users sharing the same device.
(back to top)
Oclean: This water flosser must be the most streamlined, elegantly designed flosser I've ever seen. I wanted to love it. Unfortunately, even on the lowest-intensity setting, the tips suctioned my inner cheeks and underneath my tongue and vibrated too forcefully for me.
Philips Sonicare Power Flosser 3000: I loved this compact countertop version of the Philips Sonicare Cordless Power Flosser, but since it offers the same features as its cordless counterpart, we chose to include the cordless version instead.
Waterpik Cordless Water Flosser: It's a basic version of the newer and more feature-rich Waterpik models on our list, so we chose not to include this water flosser. However, it's a solid option for those who want a simple, cost-effective flosser.
Proclaim Custom-Jet Oral Health System: This next-level water flosser and oral health system is worth the investment if you have the cash to spend. The key is the system's custom mouthpiece, which requires a trip to your local dentist for an oral scan (the mouthpiece comes with custom jets based on your mouth's specific physiology). Unfortunately, it costs a not-insignificant $600 (although it is FSA/HSA eligible), so it didn't make our list. That said, if you're serious about getting the deepest at-home clean you can, this is like the Rolls-Royce of water flossers.
Burst Water Flosser: This water flosser has a powerful stream that does a great job clearing away debris but may be too intense for some. The water reservoir is smaller than other brands, and refilling it can be inconvenient.
Quip Rechargeable Compact Water Flosser: With a rotating nozzle, the Quip easily reaches crowded areas of my mouth and feels comfortable (not too bulky) to hold. Its compact size makes it a good option for on-the-go, but it's much pricier than our top travel pick.
Nicwell Cordless Portable Dental Flosser: This popular option has a large enough water reservoir and a strong enough battery life to adequately clean between all your teeth, and we like that it's lightweight and portable. You can also frequently find it on sale for around $30, but its regular retail price of $50 seems high when compared to the other, similar rechargeable models on our list.
Waterpik Sonic-Fusion 2.0: Waterpik has a solid lineup of ADA-accepted water flossers, and this one's no exception. A bonus? It's also a toothbrush, aka a "flossing toothbrush." If you're looking for a water flosser and toothbrush in one, this is a great dentist-recommended option.
Moon Water Flosser: With a sleek, compact design, Moon's water flosser won't take up much counter space. I found it effective, but it only has two pressure settings: gentle mode and deep clean, while our "best overall" pick has 10 for roughly the same price. It does come with a unique "tongue scraping" tip that most water flossers don't offer, and I found it fun to use.
(back to top)
JoAnn Gurenlian, RDH, MS, PhD, AAFAAOM, FADHA, dental adviser at Proclaim Health in Philadelphia
Casey Johnson, DDS, board-certified orthodontist at All Kids Dental in Colorado
Chelsea Perry, DMD, founder of Elite Dental Studio in Westborough, Mass.
(back to top)
Our health content is for informational purposes only and is not intended as professional medical advice. Consult a medical professional on questions about your health.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
BrightGene Presents Positive Phase 2 Data for Dual GLP-1R/GIPR Agonist for Weight Management and Type 2 Diabetes and Preclinical Data for Novel Amylin Analog at American Diabetes Association's 85th Scientific Sessions
Phase 2 data highlights best-in-class potential of dual GLP-1R/GIPR agonist BGM0504 for weight management and metabolic risk reduction in individuals with type 2 diabetes and overweight, non-obese individuals Preclinical data for BGM1812 supports further development as next-generation amylin analog for obesity treatment SUZHOU, China, June 24, 2025 /PRNewswire/ -- BrightGene Pharmaceutical Co., Ltd., an international, innovation-driven pharmaceutical company, presented data from two Phase 2 studies for BGM0504, its investigational dual agonist targeting glucagon-like peptide-1 receptor (GLP-1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR), along with preclinical data for its novel amylin analog, BGM1812, at the 85th Scientific Conference of the American Diabetes Association (ADA). Results from two separate Phase 2 studies in BGM0504 demonstrated significant potential for weight management and metabolic risk reduction in individuals with type 2 diabetes (including superiority to semaglutide), and in overweight and obese non-diabetic individuals, respectively. Preclinical data for BGM1812 demonstrated superior receptor activation, robust weight loss and synergistic potential with GLP-1/GIP dual agonism, supporting its development as a next-generation amylin analog for obesity treatment. "These Phase 2 data highlight the significant, best-in-class potential of BGM0504 as a treatment for type 2 diabetes and obesity, including potential superiority to semaglutide and a strong safety profile, while our preclinical data for BGM1812 support its continued development as a next-generation amylin analog for obesity treatment, underscoring the additional promise in our pipeline," said Dr. Jiandong Yuan, CEO, BrightGene. "Building on our extensive peptide expertise and strong heritage in high-quality, efficient drug development, BrightGene is committed to accelerating innovative therapeutics to help address unmet patient needs in metabolic disease and other important therapeutic areas." BGM0504 Phase 2 Study in Type 2 Diabetes This multicenter, randomized, double-blind (placebo-controlled) and open-label (semaglutide positive-controlled) evaluated the pharmacokinetics, safety and efficacy of once-weekly subcutaneous injection of BGM0504 across the primary endpoint, change from baseline in HbA1c at Week 12 of target dose administration, and multiple secondary endpoints including PPG-2h, FPG, body weight, HbA1c and combined HbA1c/body weight targets proportions, HOMA2-B, blood lipids, systolic blood pressure (SBP) and diastolic blood pressure (DBP). The study enrolled 67 participants with type 2 diabetes between the ages of 18 and 65, 64 received dose after randomization, randomized into five groups: 5mg (n=13), 10mg (n=12), 15mg (n=13), positive-control group (semaglutide; n=16) or placebo (n=13). Enrolled participants included adults with a baseline HbA1c between 7.0% and 10.0%, and a body mass index (BMI) between 19.5 and 35 kg/m2. At Week 12 of target dose administration, treatment with BGM0504 resulted in reductions in HbA1c across the three dose groups that were statistically significant compared with the placebo group and greater than treatment with semaglutide, including -1.72% in the 5mg dose group, -1.94% in the 10mg dose group, and -2.48% in 15mg dose group, compared to -1.43% in semaglutide and -0.28% in placebo. Similar results were observed in multiple secondary endpoints, including PPG-2h, FPG, body weight, and HbA1c and combined HbA1c/body weight target proportions, while varying improvement trends were observed in HOMA2-B, blood lipids, SBP and DBP. Most treatment emergent adverse events (TEAEs) were Grade 1 or 2 during the rapid titration stage and gradually tolerated after reaching the target dose. The most common treatment-related gastrointestinal AEs were diarrhea, nausea and abdominal distension; no hypoglycemic or other unexpected adverse reactions occurred. BGM0504 Phase 2 Study in Obesity This randomized, double-blind, placebo-controlled study evaluated the safety and efficacy of BGM0504 in 120 Chinese adults with obesity during multiple-dose administration (subcutaneous injection). Enrolled participants included adults with a BMI ≥ 24kg/m2 (mean BMI at enrollment ≥ 27kg/m2) with prediabetes and/or at least one obesity-related comorbidity, or adults with obesity (BMI≥ 28kg/m2, mean BMI at enrollment ≥ 30kg/m2). Participants were randomized into four groups: 5 mg (n=30), 10 mg (n=30), 15 mg(n=30), or placebo (n=30). The study consisted of a titration phase (2-6 weeks), 24-week treatment with once-weekly dosing, and a 2-week follow-up. Study results demonstrated reductions in waist circumference ranging from −8.0 cm to −12.98 cm (p < 0.001), and significant weight reductions ranging from -10.77% to 19.78% (LS means, placebo adjusted). Results also showed improvements in systolic blood pressure ranging from −11.60 to −13.03 mmHg and diastolic blood pressure ranging from −5.98 to −7.50 mmHg (p < 0.05). Secondary outcomes further supported the efficacy of BGM0504, and all doses were well tolerated with common adverse events. BGM1812 Preclinical Study In a preclinical study, BGM1812 demonstrated strong receptor activation with 1.8× and 2.2× increased agonist activity (EC50) at the amylin and calcitonin receptors, respectively, versus petrelintide. The agonist also demonstrated dose-dependent weight loss in 0.012 - 0.12 mg/kg dose range in the diet-induced obese (DIO) rat model. At 0.04 mg/kg, BGM1812 achieved greater weight reduction than petrelintide. In addition, BGM1812 significantly preserved relative lean mass while reducing relative fat mass. Additionally, the combination of BGM1812 and BGM0504 resulted in greater and more sustained weight loss than either semaglutide+cagrilintide or amycretin in the DIO rat model. About BGM0504 The peptide hypoglycemic drug BGM0504 injection is a dual agonist of GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide) receptors independently developed by BrightGene. BGM0504 can stimulate the downstream pathways of GIP and GLP-1, produce biological effects such as controlling blood sugar, reducing weight and treating non-alcoholic steatohepatitis (NASH), and show potential for the treatment of various metabolic diseases. BGM0504 is currently in Phase 3 trials in China for weight management and type 2 diabetes and has completed a Phase 1 bridging study for weight management in the U.S. To date, BGM0504 has been investigated in more than 1,000 patients and demonstrated superior efficacy and a strong safety profile. About BGM1812 BGM1812 is a novel amylin analog designed using AI/ML-driven optimization to enhance agonist activities and formulation properties. A potent and ultra long-acting amylin, BGM1812 has the potential to be a once weekly oral tablet. About BrightGene BrightGene is an international, innovation-driven pharmaceutical company, listed on the Shanghai Stock Exchange, dedicated to developing and manufacturing high-quality therapeutics to address unmet patient needs. Founded in 2001, BrightGene has evolved from an established global leader in high-hurdle generics and biosimilars to developing innovative metabolic and respiratory therapeutics. An established leader in challenging chemistry and conjugation, BrightGene has proprietary, cutting-edge platforms in peptides, siRNA, nanobodies, as well as advanced formulations, and 272 patents. The company remains a global supplier of 15 APIs and 2 drug products to the US and EU. BrightGene is headquartered in China. Additional information is available at View original content: SOURCE Bright Gene Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


USA Today
2 hours ago
- USA Today
Eric Dane explains why he feels 'lucky' amid ALS battle: See video
"Euphoria" actor Eric Dane said he is grateful and privileged to have financial stability amid his ongoing battle with ALS, but warned that many other American families are not. The "Grey's Anatomy" alum spoke at U.S. Health Secretary Robert F. Kennedy Jr.'s hearing to discuss the Monday, June 23 announcement that several health insurance companies plan to simplify and reduce prior authorizations over the next year and a half. UnitedHealthcare, Blue Cross Blue Shield and Kaiser Permanente were among the companies that aim to streamline the common process of vetting requests before allowing doctors to bill for medical services or prescriptions. In April, the 52-year-old San Francisco native revealed he was diagnosed with amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease. At Monday's press conference, Dane applauded the insurance industry for coming together to offer other ALS patients "more certainty, faster answers and more hopes for recovery." "Some of you may know from TV shows such as 'Grey's Anatomy' which I play a doctor, but I am here to today to speak briefly as a patient," he said. "When that diagnosis hits and you find out that you're sick, your life becomes filled with great uncertainty. And the worst thing we could do is add even more uncertainty for patients and their loved ones with unnecessary prior authorization." Prior authorization has criticized by many doctors and patients who argue the practice routinely delays or denies care, according to various surveys and government oversight reports. The newly unveiled changes could impact 257 million Americans who are covered by private commercial insurance, Medicare Advantage and Medicaid managed care plans. "Anything we can do to give patients more certainty with fewer delays is a worthwhile endeavor," he said. "I've been fortunate and have the means to access great care. I am lucky. Not everyone is in the same position." Eric Dane says right arm has 'completely stopped working' Last week, Dane shared that his ALS has progressed to the point that his right arm has stopped functioning. "I have one functioning arm," he told Diane Sawyer on a June 16 "Good Morning America" interview. "My left side is functioning. My right side has completely stopped working." The actor said he expects just a few more months before "I won't have my left hand either," which he called "sobering." And while he luckily has not had any issues walking, he added that he's also "worried" about his legs. Dane is arguably best known for playing played the plastic surgeon Dr. Mark Sloan, nicknamed "McSteamy" on ABC's "Grey's Anatomy" from 2006 to 2012. He is also expected to reprise his role as Nate Jacob's father Cal Jacobs in the upcoming third season of HBO's "Euphoria." Contributing: Ken Alltucker and Brendan Morrow, USA TODAY
Yahoo
2 hours ago
- Yahoo
Biden's White House physician to appear before House panel
Former President Biden's White House doctor, Kevin O'Connor, is set to appear for a deposition before the House Oversight and Government Reform Committee next month, a committee spokesperson confirmed to The Hill. O'Connor is scheduled to be deposed on July 9 as committee Chair Rep. James Comer (R-Ky.) expands his panel's probes into Biden's mental acuity while in office, demanding interviews with former top aides. Comer issued a subpoena for testimony from O'Connor earlier this month. The Oversight committee is looking into Biden's cognitive functions and autopen usage during his White House tenure. Biden and his wife, Jill, have denied allegations that the former president experienced decline while in office. New books about the end of former President Biden's term and his recent diagnosis with an aggressive form of prostate cancer have put a spotlight on O'Connor, who has served as Biden's physician since the Obama administration, when Biden was vice president. He was the Biden family physician after the Democrats left office, and was selected to serve again when Biden became president in 2021. O'Connor's last physical exam of Biden, dated February 2024, described the then-president as 'fit for duty,' adding that he 'fully executes all of his responsibilities without any exemptions or accommodations.' Comer had previously asked O'Connor to appear before the Oversight panel for a transcribed interview, saying in a late May letter that 'the Committee seeks information to ensure accurate information was provided to the American people and your health reports were not subject to any improper influence.' O'Connor's team refused that request, his lawyers citing in part a D.C. code concerning physicians' disclosure of patient information to a court without consent, according to the June letter from Comer issuing the subpoena. NBC News first reported on Connor's scheduled July appearance. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.